.
.
.
.
.
Hereditary cancers result from inherited gene mutations that increase the likelihood of developing certain cancers, including breast, ovarian, colorectal, and prostate cancers. Early identification of these genetic predispositions help in taking preventive measures, such as increased screening, lifestyle adjustments, or preventive surgeries, to reduce the chance of developing cancer.
HEALTHSTRING, analyses over 800 cancer causing genes and their mutations, offering the most comprehensive preventive screening available globally.
.
Blood
.
Breast
.
Lung
.
Mouth
.
Breast
.
Lung
.
Blood
.
Thyroid
.
Stomach
.
Ovary
.
Prostate
.
Mouth
.
Liver
.
Bone
.
Brain
.
Pancreas
.
Skin
.
Kidney
.
Heart
.
Rectum
.
Eye
.
Colon
.
Throat
.
Adrenal gland
.
Blood vessels
.
Bone marrow
.
Connective tissue
.
Gastrointestinal tract
.
Endocrine system
.
Endometrium
.
Esophagus
.
Gastrointestinal tract
.
Sebum gland
.
Gums
.
Hypothalamus
.
Lymphoid tissue
.
Nerves
.
Pituitary gland
.
Soft tissue
Genetic diseases are often progressive and can become life-threatening when triggered by lifestyle or environmental factors. Early risk identification enables proactive prevention.
We analyze all functional regions of the DNA using proprietary, population-agnostic, machine-learning-driven algorithms to detect variations that could lead to diseases.
With the highest sensitivity and specificity in detection, the results are presented in a clinically actionable format, adhering to international guidelines for DNA screening.
.
Single-base level investigation of genetic risks.
.
Population-agnostic and evidence based reporting.
.
Individualised insights, enabling precise health strategies.
.
.
.
Mutation (DNA Error)
MLH1
Lynch syndrome 2
Raises the risk of various cancers, especially colorectal cancer.
Mutation
: 3-37020354-C-G ENST0000023 1790.8 c.929C >G p.Thr310Arg
Type
: Missense
Zygosity
: Heterozygous
Inheritance
: Autosomal Dominant
Classification
: Likely Pathogenic
Lynch syndrome is an inherited genetic condition that increases the risk of various types of cancer, particularly colorectal cancer and endometrial cancer. Lynch syndrome is caused by mutations in genes that are responsible for DNA repair...
.
.
.
.
.
.
.
.
.
.
We sequence all the functional regions in your DNA using Next Generation DNA Sequencing technology to identify your unique genetic variants. Our proprietary AI/ML-driven algorithms analyse your DNA to detect genetic factors linked to the covered diseases.
In 4 weeks, you receive a personalised, clinical-grade genetic health report with actionable recommendations.
HEALTHSTRING™ identifies the risk of over 6,000 genetic conditions before disease onset, enabling physicians to develop preventive strategies such as lifestyle changes or medical treatments to avoid adverse health events.
Knowing potential threats in advance can optimise future health screenings, customised to your conditions, and to catch early signs well before visible signs and symptoms. Mitigate set backs in advance, and enrich your healthspan.
Such Informed decision-making at the right time maximises your potential, and staying healthy always provides more opportunities in life.
HEALTHSTRING™ uses the most advanced DNA sequencing technology, with a demonstrated accuracy of 99.9999%. Our proprietary, population-agnostic machine learning algorithms for data interpretation detect disease risks with 100% specificity.
The clinical-grade genetic health reports are prepared in accordance with international clinical guidelines prescribed by ACMG-AMP (American College of Medical Genetics and Genomics-Association for Molecular Pathology), ASCO (American Society of Clinical Oncology), and NCCN (National Comprehensive Cancer Network).
HEALTHSTRING™ delivers precise genetic health reports with 100% specificity, unlike the population-relative risk scores provided by other genetic screening products.
Our approach surpasses the outdated, marker-based methods used by others, which typically have less than 80% specificity (>20% false positives) and only 40% sensitivity (>60% false negatives). We decode every letter of targeted gene segments in your DNA, ensuring comprehensive coverage and detailed analysis.
HEALTHSTRING™’s proprietary, population-agnostic approach, powered by machine learning algorithms sets us apart. It operates independently of the genetic frequencies in public databases, which are often biased toward Caucasian populations.
HEALTHSTRING™ is suitable for anyone interested in proactively preventing life-limiting health conditions tailored to their specific needs, regardless of age, gender, or clinical history.
Those with specific health concerns, a family history of certain conditions, or individuals planning for family expansion may find these tests particularly relevant.
After placing an order, a buccal swab collection kit will be sent to your address. Follow the simple instructions in the kit to collect your sample. Once done, register the kit on the SugarStrings.ai website, and we will arrange for the sample to be picked up from your address.
HEALTHSTRING™ report will be delivered to you within 4 weeks from the date of receipt of your sample at the laboratory. Regular emails will keep you posted on the progress.
.